Literature DB >> 22998685

Association between obesity measured by different parameters and severity of psoriasis.

Gleison Vieira Duarte1, Maria de Fatima S P Oliveira, Thiago M Cardoso, Ivonise Follador, Thadeu S Silva, Carolina M A Cavalheiro, Walker Nonato, Edgar M Carvalho.   

Abstract

BACKGROUND: Obesity has been associated with the severity of psoriasis, but this relationship is not completely understood.
OBJECTIVES: This study aimed to evaluate associations between the severity of psoriasis and weight excess as determined using a variety of parameters.
METHODS: A cross-sectional study was performed in 296 psoriasis patients. Their body mass index (BMI), waist circumference (WC), and waist : hip ratio (WHR) values were compared with results on a psoriasis area severity index (PASI).
RESULTS: The frequency of severe psoriasis was higher in men (P < 0.05). Direct correlations were established between PASI scores and each of BMI (R = 0.0154, P = 0.01), WC (R = 0.207, P = 0.001), and WHR (R = 0.164, P = 0.007).
CONCLUSIONS: This study extends previous reports of an association between psoriasis and obesity and shows a direct correlation between obesity as measured according to different parameters and psoriasis severity.
© 2012 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2012        PMID: 22998685     DOI: 10.1111/j.1365-4632.2011.05270.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  19 in total

1.  Genetic Epidemiology of Psoriasis.

Authors:  Rashmi Gupta; Maya G Debbaneh; Wilson Liao
Journal:  Curr Dermatol Rep       Date:  2014-03

2.  Psoriasis and Sleep Apnea: A Danish Nationwide Cohort Study.

Authors:  Alexander Egeberg; Usman Khalid; Gunnar Hilmar Gislason; Lotus Mallbris; Lone Skov; Peter Riis Hansen
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

3.  Psychosocial aspects of obesity in adults with psoriasis: A systematic review.

Authors:  N T Pavlova; K Kioskli; C Smith; F Picariello; L Rayner; R Moss-Morris
Journal:  Skin Health Dis       Date:  2021-05-03

4.  The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.

Authors:  A Campanati; G Ganzetti; A Di Sario; A Damiani; L Sandroni; L Rosa; A Benedetti; A Offidani
Journal:  J Gastroenterol       Date:  2012-10-13       Impact factor: 7.527

5.  Correlation between psoriasis' severity and waist-to-height ratio.

Authors:  Gleison Vieira Duarte; Larissa Porto da Silva
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

Review 6.  Psoriasis: classical and emerging comorbidities.

Authors:  Maria de Fátima Santos Paim de Oliveira; Bruno de Oliveira Rocha; Gleison Vieira Duarte
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

7.  Itching sensation in psoriatic patients and its relation to body mass index and IL-17 and IL-31 concentrations.

Authors:  Magdalena Czarnecka-Operacz; Adriana Polańska; Magdalena Klimańska; Ewa Teresiak-Mikołajczak; Marta Molińska-Glura; Zygmunt Adamski; Dorota Jenerowicz
Journal:  Postepy Dermatol Alergol       Date:  2015-12-11       Impact factor: 1.837

8.  Diagnosis and underdiagnosis of comorbidities in psoriasis patients - need for a multidisciplinary approach.

Authors:  Gleison Vieira Duarte; Maria de Fátima S P de Oliveira; Ivonise Follador; Thadeu Santo Silva; Edgar Marcelino de Carvalho
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

9.  The relation between visceral fat markers and cardiometabolic disease risks in psoriasis patients.

Authors:  Arzu Ataseven; Ruhusen Kutlu; Latife Uzun
Journal:  North Clin Istanb       Date:  2021-05-24

10.  The relationship between body mass index, waist circumference and psoriatic arthritis in the Turkish population.

Authors:  Dilek Biyik Ozkaya; Nahide Onsun; Bugce Topukçu; Ozlem Su; Anil Gulsel Bahalı; Didem Dizman; Aylin Rezvani; Omer Uysal
Journal:  Postepy Dermatol Alergol       Date:  2016-06-17       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.